Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synthetic chitosan + doxepin mouthwash for painful oral ulcers
IRCT20120101008585N5Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2018
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, double-blind trial of chitosan and doxepin in Oral ulcer (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Pain intensity by visual analogue scale and Oral ulcer size. Started Feb 2018; status: completed.
02
Drugs
chitosandoxepin
03
Conditions
Oral ulcer
Beyond the preview
Go deeper on IRCT20120101008585N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120101008585N5.